drugset / Trial / NCT02357849

Fluoxetine vs Aripiprazole Comparative Trial (FACT)

NCT02357849

Phase 4 Terminated 9 enrolled Northwell Health
RandomizedParallel-groupQuadruple-blindOther

Summary

We are conducting a randomized, 24-week, double-blind study, comparing fluoxetine with aripiprazole in 48 patients with attenuated positive symptoms at a level of at least moderate severity.

Timeline

Start
2014-07
Primary completion
2022-04-04
Completion
2022-04-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aripiprazole Other / unclassified 5 mg
Comparator Aripiprazole Other / unclassified 30 mg
Comparator Fluoxetine Small molecule 10 mg
Comparator Fluoxetine Small molecule 60 mg

Indications

No indication recorded.